Significance of the Neutrophil-to-Lymphocyte Ratio in p16-Negative Squamous Cell Carcinoma of Unknown Primary in Head and Neck

被引:11
|
作者
Xu, Chunmiao [1 ]
Yuan, Junhui [1 ]
Du, Wei [2 ]
Wu, Junfu [2 ]
Fang, Qigen [2 ]
Zhang, Xu [2 ]
Li, Hailiang [1 ]
机构
[1] Zhengzhou Univ, Henan Canc Hosp, Affiliated Canc Hosp, Dept Radiol, Zhengzhou, Peoples R China
[2] Zhengzhou Univ, Henan Canc Hosp, Affiliated Canc Hosp, Dept Head Neck & Thyroid, Zhengzhou, Peoples R China
来源
FRONTIERS IN ONCOLOGY | 2020年 / 10卷
关键词
head neck squamous cell carcinoma; squamous cell carcinoma of unknown primary; neutrophil-to-lymphocyte ratio; prognosis; cancer cachexia; CANCER CACHEXIA; MANAGEMENT; METASTASES; HALLMARKS; SURVIVAL; ORIGIN; IMPACT; P16;
D O I
10.3389/fonc.2020.00039
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective: The neutrophil-to-lymphocyte ratio (NLR) has been reported to be associated with survival in solid malignancies. The main goal was to evaluate the prognostic significance of the NLR in patients with p16-negative squamous cell carcinoma of unknown primary (SCCUP) in head and neck. Methods: The association between the NLR and clinical pathologic variables was evaluated by the chi-square test. The primary endpoint of interest was disease-specific survival (DSS). Univariate and Coxmodel analyses were used to evaluate prognostic factors. Results: A total of 153 patients were included in the analysis. Cancer cachexia was noted in 10 patients. The mean NLR value was 3.9 (range: 1.4-8.3). A high NLR was significantly associated with cancer cachexia development. The 5-year DSS rate was 58%. In patients with NLRs varying from 1.4 to 3.7, the 5-year DSS rate was 71%; in patients with NLRs varying from 3.7 to 6.0, the 5-year DSS rate was 57%; in patients with NLRs varying from 6.0 to 8.3, the 5-year DSS rate was 39%, and the difference was significant (p = 0.001). Further Cox model analysis confirmed the independence of the NLR in predicting survival. Conclusions: In patients with p16-negative SCCUP, an NLR >= 6.0 is significantly associated with worse prognosis.
引用
收藏
页数:6
相关论文
共 50 条
  • [1] Neutrophil-to-lymphocyte ratio: Prognostic indicator for head and neck squamous cell carcinoma
    Rosculet, Nicholas
    Zhou, Xian Chong
    Ha, Patrick
    Tang, Mei
    Levine, Marshall A.
    Neuner, Geoffrey
    Califano, Joseph
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2017, 39 (04): : 662 - 667
  • [2] Predictive Value of the Pretreatment Neutrophil-to-Lymphocyte Ratio in Head and Neck Squamous Cell Carcinoma
    Chen, Miao-Fen
    Tsai, Ming-Shao
    Chen, Wen-Cheng
    Chen, Ping-Tsung
    JOURNAL OF CLINICAL MEDICINE, 2018, 7 (10):
  • [3] Neutrophil-to-lymphocyte ratio and overall survival in all sites of head and neck squamous cell carcinoma
    Rachidi, Saleh
    Wallace, Kristin
    Wrangle, John M.
    Day, Terry A.
    Alberg, Anthony J.
    Li, Zihai
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2016, 38 : E1068 - E1074
  • [4] Prognostic significance of neutrophil-to-lymphocyte ratio in esophageal squamous cell carcinoma
    Sakin, Aysegul
    Alay, Murat
    Sahin, Suleyman
    Aydemir, Ozan
    Aldemir, Mehmet Naci
    Sakin, Abdullah
    Kotan, Cetin
    NORTHERN CLINICS OF ISTANBUL, 2021, 8 (05) : 435 - 442
  • [5] Significance of the neutrophil-to-lymphocyte ratio in young patients with oral squamous cell carcinoma
    Zhang, Baixia
    Du, Wei
    Gan, Kang
    Fang, Qigen
    Zhang, Xu
    CANCER MANAGEMENT AND RESEARCH, 2019, 11 : 7597 - 7603
  • [6] Low neutrophil-to-lymphocyte ratio is a negative prognosticator in oral squamous cell carcinoma
    Mattavelli, D.
    Lombardi, D.
    Missale, F.
    Calza, S.
    Battocchio, S.
    Paderno, A.
    Bozzola, A.
    Vermi, W.
    Piazza, C.
    Nicolai, P.
    RADIOTHERAPY AND ONCOLOGY, 2019, 132 : 97 - 97
  • [7] Multivariate analysis of preoperative and postoperative neutrophil-to-lymphocyte ratio as an indicator of head and neck squamous cell carcinoma outcome
    Muhaxheri, G.
    Boras, V. Vucicevic
    Fucic, A.
    Plavec, D.
    Sekerija, M.
    Filipovic, M.
    Grsic, K.
    Stubljar, B.
    Krnic, T.
    Vrdoljak, B.
    INTERNATIONAL JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY, 2018, 47 (08) : 965 - 970
  • [8] Neutrophil-to-lymphocyte ratio as a predictor of survival in head and neck squamous cell carcinoma patients treated with cisplatin.
    Kao, Derek
    Ferrandino, Rocco
    Roof, Scott
    Sigel, Keith Magnus
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E18004 - E18004
  • [9] Neutrophil-to-lymphocyte ratio in head and neck cancer
    Haddad, Carol R.
    Guo, Linxin
    Clarke, Stephen
    Guminski, Alex
    Back, Michael
    Eade, Thomas
    JOURNAL OF MEDICAL IMAGING AND RADIATION ONCOLOGY, 2015, 59 (04) : 514 - 519
  • [10] Neutrophil-to-lymphocyte ratio associates with intratumoral myeloid predominance and clinical outcomes of pembrolizumab in head and neck squamous cell carcinoma
    Morimoto, Hiroki
    Tsujikawa, Takahiro
    Miyagawa-Hayashino, Aya
    Kimura, Alisa
    Saburi, Sumiyo
    Mitsuda, Junichi
    Yoshimura, Kanako
    Ohmura, Gaku
    Mukudai, Shigeyuki
    Nagao, Hikaru
    Sugiyama, Yoichiro
    Saya, Shibata
    Ogi, Hiroshi
    Konishi, Eiichi
    Itoh, Kyoko
    Hirano, Shigeru
    CANCER RESEARCH, 2023, 83 (07)